KOPRAN
Back to Income Statement
|
KOPRAN Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹615 Cr | ₹551 Cr | ₹478 Cr | ₹492 Cr | ₹359 Cr |
What is the latest Revenue of KOPRAN ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹615 Cr |
| Mar2024 | ₹551 Cr |
| Mar2023 | ₹478 Cr |
| Mar2022 | ₹492 Cr |
| Mar2021 | ₹359 Cr |
How is Revenue of KOPRAN Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹615 Cr | 11.54 | |
| Mar2024 | ₹551 Cr | 15.38 | |
| Mar2023 | ₹478 Cr | -2.91 | |
| Mar2022 | ₹492 Cr | 36.81 | |
| Mar2021 | ₹359 Cr | - | |
Compare Revenue of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹635.1 Cr | 2.5% | 4.8% | -29.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 2.5% |
4.8% |
-29.5% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses